Grossman I - Search Results

1

Using genetics to enable studies on the prevention of Alzheimer's disease.

Crenshaw DG, Gottschalk WK, Lutz MW, Grossman I, Saunders AM, Burke JR, Welsh-Bohmer KA, Brannan SK, Burns DK, Roses AD. Crenshaw DG, et al. Among authors: grossman i. Clin Pharmacol Ther. 2013 Feb;93(2):177-85. doi: 10.1038/clpt.2012.222. Epub 2012 Nov 7. Clin Pharmacol Ther. 2013. PMID: 23249780 Free PMC article.

2

Alzheimer's disease: diagnostics, prognostics and the road to prevention.

Grossman I, Lutz MW, Crenshaw DG, Saunders AM, Burns DK, Roses AD. Grossman I, et al. EPMA J. 2010 Jun;1(2):293-303. doi: 10.1007/s13167-010-0024-3. Epub 2010 Jun 29. EPMA J. 2010. PMID: 21124753 Free PMC article.

3

Characterization of the poly-T variant in the TOMM40 gene in diverse populations.

Linnertz C, Saunders AM, Lutz MW, Crenshaw DM, Grossman I, Burns DK, Whitfield KE, Hauser MA, McCarthy JJ, Ulmer M, Allingham R, Welsh-Bohmer KA, Roses AD, Chiba-Falek O. Linnertz C, et al. Among authors: grossman i. PLoS One. 2012;7(2):e30994. doi: 10.1371/journal.pone.0030994. Epub 2012 Feb 16. PLoS One. 2012. PMID: 22359560 Free PMC article.

4

TOMM40 and APOE: Requirements for replication studies of association with age of disease onset and enrichment of a clinical trial.

Roses AD, Lutz MW, Crenshaw DG, Grossman I, Saunders AM, Gottschalk WK. Roses AD, et al. Among authors: grossman i. Alzheimers Dement. 2013 Mar;9(2):132-6. doi: 10.1016/j.jalz.2012.10.009. Epub 2013 Jan 18. Alzheimers Dement. 2013. PMID: 23333464 Free article. Review.

5

Pipeline pharmacogenetics: a novel approach to integrating pharmaco-genetics into drug development.

Akkari PA, Swanson TW, Crenshaw DG, Grossman I, Sundseth S, Burns DK, Roses AD. Akkari PA, et al. Among authors: grossman i. Curr Pharm Des. 2009;15(32):3754-63. doi: 10.2174/138161209789649538. Curr Pharm Des. 2009. PMID: 19925426 Review.

6

Healthy aging and preclinical dementia: the United States-Israel Longitudinal Database project.

Khachaturian AS, Chapman J, Farrer L, Friedland RP, Ebstein R, Grossman I, Hendler T, Hermann B, Inzelberg R, Johnson S, Khachaturian ZS, Lichter-Shapira I, Makeeva O, Mayrl R, Mizrahi E, Roses AD, Sager M, Fraifeld S. Khachaturian AS, et al. Among authors: grossman i. Alzheimers Dement. 2010 Nov;6(6):475-81. doi: 10.1016/j.jalz.2010.10.001. Alzheimers Dement. 2010. PMID: 21044777

7

Genetic determinants of variable metabolism have little impact on the clinical use of leading antipsychotics in the CATIE study.

Grossman I, Sullivan PF, Walley N, Liu Y, Dawson JR, Gumbs C, Gaedigk A, Leeder JS, McEvoy JP, Weale ME, Goldstein DB. Grossman I, et al. Genet Med. 2008 Oct;10(10):720-9. doi: 10.1097/GIM.0b013e3181863239. Genet Med. 2008. PMID: 18813134 Free PMC article.

8

ADME pharmacogenetics: current practices and future outlook.

Grossman I. Grossman I. Expert Opin Drug Metab Toxicol. 2009 May;5(5):449-62. doi: 10.1517/17425250902902322. Expert Opin Drug Metab Toxicol. 2009. PMID: 19416082 Review.

9

Routine pharmacogenetic testing in clinical practice: dream or reality?

Grossman I. Grossman I. Pharmacogenomics. 2007 Oct;8(10):1449-59. doi: 10.2217/14622416.8.10.1449. Pharmacogenomics. 2007. PMID: 17979518 Review.

10

Global pharmacogenetics: genetic substructure of Eurasian populations and its effect on variants of drug-metabolizing enzymes.

Makeeva O, Stepanov V, Puzyrev V, Goldstein DB, Grossman I. Makeeva O, et al. Among authors: grossman i. Pharmacogenomics. 2008 Jul;9(7):847-68. doi: 10.2217/14622416.9.7.847. Pharmacogenomics. 2008. PMID: 18597650

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page